E-Therapeutics PLC
LSE:ETX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E-Therapeutics PLC
LSE:ETX
|
UK |
|
A
|
Abercrombie & Fitch Co
F:AFT
|
US |
|
Intertrust NV
F:4IT
|
NL |
|
E
|
Eli Lilly and Co
BMV:LLY
|
US |
|
M
|
Maxim Global Bhd
KLSE:MAXIM
|
MY |
|
S
|
STI Group Inc
OTC:STUO
|
US |
|
BRP Inc
TSX:DOO
|
CA |
|
MS&AD Insurance Group Holdings Inc
F:59M0
|
JP |
|
B
|
Binasat Communications Bhd
KLSE:BINACOM
|
MY |
|
Transcat Inc
F:TR8
|
US |
|
Mavi Giyim Sanayi ve Ticaret AS
IST:MAVI.E
|
TR |
|
G
|
Global Sukses Digital Tbk PT
IDX:DOSS
|
ID |
|
B
|
Banco Santander SA
VSE:SAN
|
ES |
|
Takashimaya Co Ltd
OTC:TKSHF
|
JP |
|
Lime Technologies AB (publ)
STO:LIME
|
SE |
|
PT Dayamitra Telekomunikasi Tbk
IDX:MTEL
|
ID |
|
Y
|
Yankuang Energy Group Co Ltd
SWB:YZCA
|
CN |
|
Traka Resources Ltd
ASX:TKL
|
AU |
Shareholder Yield
Current shareholder yield for ETX is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
ETX Price
E-Therapeutics PLC
| Average Annual Return | -6.73% |
| Standard Deviation of Annual Returns | 75.87% |
| Max Drawdown | -83% |
| Market Capitalization | 52.4m GBX |
| Shares Outstanding | 584 336 000 |
| Percentage of Shares Shorted |
N/A
|
